Regeneron Pharmaceuticals, Inc.
MX ˙ BMV ˙ US75886F1075
SecurityMX:REGN / Regeneron Pharmaceuticals, Inc.
InstitutionNorth Point Portfolio Managers Corp/oh
Latest Disclosed Ownership16,743 shares
Latest Disclosed Value $ 12,936,312
North Point Portfolio Managers Corp/oh reports 0.01% decrease in ownership of REGN / Regeneron Pharmaceuticals, Inc.

On April 24, 2026 - North Point Portfolio Managers Corp/oh filed a 13F-HR form disclosing ownership of 16,743 shares of Regeneron Pharmaceuticals, Inc. (MX:REGN) valued at $12,936,312 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 28, 2026 disclosing 16,744 shares of Regeneron Pharmaceuticals, Inc.. This represents a change in shares of -0.01% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 16,743 -1 -0.01 12,936 0.09 2.3041
2026-01-28 2025-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 16,744 13 0.08 12,925 37.39 2.1880
2025-10-23 2025-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 16,731 -146 -0.87 9,408 6.17 1.5559
2025-07-30 2025-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 16,877 -357 -2.07 8,861 -18.94 1.5200
2025-04-22 2025-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 17,234 197 1.16 10,930 -9.94 1.9167
2025-01-22 2024-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 17,037 -269 -1.55 12,136 -33.29 2.1117
2024-10-24 2024-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 17,306 -32 -0.18 18,193 -0.16 2.9168
2024-07-29 2024-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 17,338 -678 -3.76 18,223 5.09 3.2076
2024-04-23 2024-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 18,016 65 0.36 17,340 9.98 2.9338
2024-01-23 2023-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 17,951 13 0.07 15,766 6.80 2.8732
2023-10-26 2023-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 17,938 -18 -0.10 14,762 14.42 3.0179
2023-07-24 2023-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 17,956 -5,124 -22.20 12,902 -31.97 2.5557
2023-04-25 2023-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 23,080 57 0.25 18,964 14.17 3.0183
2023-01-24 2022-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 23,023 135 0.59 16,611 5.35 2.7895
2022-10-25 2022-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 22,888 -388 -1.67 15,767 14.59 2.9394
2022-07-27 2022-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 23,276 -390 -1.65 13,759 -16.76 2.4088
2022-04-26 2022-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 23,666 -25 -0.11 16,529 10.48 2.4327
2022-01-26 2021-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 23,691 -926 -3.76 14,961 0.42 1.9607
2021-10-20 2021-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 24,617 -237 -0.95 14,898 7.32 2.0895
2021-07-28 2021-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 24,854 42 0.17 13,882 18.25 1.9149
2021-04-26 2021-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 24,812 -165 -0.66 11,740 -2.71 1.7015
2021-01-28 2020-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 24,977 -138 -0.55 12,067 -14.17 1.8190
2020-10-27 2020-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 25,115 -11,100 -30.65 14,059 -37.75 2.3914
2020-07-28 2020-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 36,215 -3,442 -8.68 22,585 16.63 4.0765
2020-04-28 2020-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 39,657 -262 -0.66 19,364 29.19 4.1976
2020-02-20 2019-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 39,919 -1,712 -4.11 14,989 29.80 2.5522
2019-10-31 2019-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 41,631 3,400 8.89 11,548 -3.49 2.1098
2019-08-02 2019-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 38,231 10,412 37.43 11,966 4.75 2.1928
2019-04-24 2019-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 27,819 143 0.52 11,423 10.51 2.1686
2019-01-24 2018-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 27,676 -1,523 -5.22 10,337 -12.38 2.2827
2018-10-26 2018-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 29,199 58 0.20 11,798 17.36 2.0074
2018-07-26 2018-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 29,141 -369 -1.25 10,053 -1.07 1.7353
2018-04-25 2018-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 29,510 629 2.18 10,162 -6.41 1.7423
2018-01-24 2017-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 28,881 -1,425 -4.70 10,858 -19.87 1.8366
2017-10-30 2017-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 30,306 306 1.02 13,550 -8.04 2.2872
2017-07-26 2017-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 30,000 756 2.59 14,734 30.02 2.5701
2017-04-25 2017-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 29,244 29,244 11,332 2.0394
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.